Suppr超能文献

新辅助放化疗后行左上肺叶切除术,联合远端主动脉弓和左锁骨下动脉切除术治疗局部晚期肺鳞状细胞癌。

Left upper lobectomy with combined distal aortic arch and left subclavian artery resection after neoadjuvant chemoradiotherapy for locally advanced lung squamous cell carcinoma.

作者信息

Takanashi Yusuke, Funai Kazuhito, Kawase Akikazu, Takahashi Daisuke, Sekihara Keigo, Matsubayashi Yuta, Hayakawa Takamitsu, Yamashita Katsushi, Shiiya Norihiko

机构信息

First Department of Surgery Hamamatsu University School of Medicine Hamamatsu Japan.

出版信息

Respirol Case Rep. 2022 Jul 12;10(8):e0994. doi: 10.1002/rcr2.994. eCollection 2022 Aug.

Abstract

T4 locally advanced non-small cell lung cancer (NSCLC) is a heterogeneous group with a great variety of involved organs and is associated with a poor prognosis. However, appropriately selected patients benefit from surgical resection. The surgical indication must be carefully considered based on the risk-benefit between high surgical stress and expected prognosis, particularly in cases with probable aortic involvement. Here, we report a long-term survival case of left upper lobe squamous cell carcinoma, in which lobectomy and combined distal aortic arch and left subclavian artery resection achieved a complete resection after induction chemoradiotherapy (CRT). Appropriate patient selection considering expected prognosis, induction CRT and complete resection under well-planned cardiopulmonary bypass are essential to achieve a long-term survival on T4 NSCLC with a probable aortic involvement.

摘要

T4期局部晚期非小细胞肺癌(NSCLC)是一个异质性群体,涉及多种器官,预后较差。然而,经过适当选择的患者可从手术切除中获益。必须根据高手术应激与预期预后之间的风险效益仔细考虑手术指征,尤其是在可能累及主动脉的病例中。在此,我们报告一例左上叶鳞状细胞癌的长期生存病例,该病例在诱导放化疗(CRT)后行肺叶切除术,并联合远端主动脉弓和左锁骨下动脉切除术实现了完整切除。考虑预期预后、诱导CRT以及在精心规划的体外循环下进行完整切除,对实现可能累及主动脉的T4期NSCLC患者的长期生存至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa6/9274099/4f20d0221ef9/RCR2-10-e0994-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验